NCT00143533 Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors Status COMPLETED Phase PHASE1
NCT00137657 Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate Resistance Status COMPLETED Phase PHASE4
NCT00124865 Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) Dose-Ranging Study Status WITHDRAWN Phase PHASE1
NCT00120744 Oral Disintegrating Ondansetron Tablet to Reduce Vomiting From Gastroenteritis in a Pediatric Emergency Department Status COMPLETED Phase NA
NCT00118872 Beneficial Bacteria to Prevent Malnutrition and Diarrhea in Pakistani Infants Status COMPLETED Phase NA
NCT00101725 A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome Status COMPLETED Phase PHASE2
NCT00098384 Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea Status COMPLETED Phase PHASE2
NCT00093353 N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma Status COMPLETED Phase PHASE1
NCT00084721 Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00050635 STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea Status COMPLETED Phase PHASE4
NCT00048971 Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy Status COMPLETED Phase N/A
NCT00040391 A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00036517 Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00033605 Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis Status COMPLETED Phase PHASE3
NCT00006269 Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer Status TERMINATED Phase PHASE3